Cleared Special

K111114 - SURESIGNS VS2 VITAL SIGNS MONITOR

K111114 is the FDA 510(k) clearance for SURESIGNS VS2 VITAL SIGNS MONITOR by Philips Medical Systems. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Special 510(k) pathway after a 29-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2011
Decision
29d
Days
Class 2
Risk

K111114 is an FDA 510(k) clearance for the SURESIGNS VS2 VITAL SIGNS MONITOR. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Philips Medical Systems (Andover, US). The FDA issued a Cleared decision on May 20, 2011 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Philips Medical Systems devices

Submission Details

510(k) Number K111114 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 2011
Decision Date May 20, 2011
Days to Decision 29 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 125d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 492
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K111114.
FULL AUTOMATIC (NIBP) BLOOD PRESSURE MONITOR
K112320 · Health & Life Co., Ltd. · Sep 2011
MICROLIFE AUTOMATIC TALKING BLOOD PRESSURE MONITOR
K111652 · Microlife Intellectual Property GmbH · Jul 2011
SURESIGNS VSI VITAL SIGNS MONITOR
K110803 · Philips Medical Systems · May 2011
HEM-4030
K110501 · Omron Healthcare, Inc. · Mar 2011
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K110018 · Andon Health Co, Ltd. · Mar 2011
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR MODEL KD-931
K102939 · Andon Health Co, Ltd. · Feb 2011